Skip Navigation

European Heart Journal 2000 21(24):1992-1994; doi:10.1053/euhj.2000.2458
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Curtin, R.
Right arrow Articles by Fitzgerald, D.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curtin, R.
Right arrow Articles by Fitzgerald, D.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

A cold start for oral glycoprotein IIb/IIIa antagonists

R. Curtin and D.J. Fitzgerald

Center for Cardiovascular Science, Royal College of Surgeons in Ireland, Dublin, Ireland

References

  1. Kong DF, Califf RM, Miller DP. Clinical outcomes of therapeutic agents thatblock the platelet glycoprotein IIb/IIIa integrin in ischaemic heart disease. Circulation. 1998;98:2829–2835[Abstract/Free Full Text]
  2. Lancet. 1997;349:1429–1435[CrossRef][ISI][Medline]
  3. N Engl J Med. 1998;338:1498–1505[Abstract/Free Full Text]
  4. N Engl J Med. 1998;339:436–443[Abstract/Free Full Text]
  5. Cannon CP, McCabe CH, Wilcox RG. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with acute coronary syndromes (OPUS-TIMI 16) trial. Circulation. 2000;102:149–156[Abstract/Free Full Text]
  6. Lancet. 2000;355:337–345[CrossRef][ISI][Medline]
  7. N Engl J Med. 2000;342:1316–1324[Abstract/Free Full Text]
  8. Heeschen C, Hamm CW. Difficulties with oral platelet glycoprotein IIb/IIIa receptor antagonists. Lancet. 2000;355:330–331[CrossRef][ISI][Medline]
  9. Simpendorfer C, Kotte-Marchant K, Lowrie M. First chronic platelet glycoprotein IIb/IIIa integrin blockade. Circulation. 1997;96:76–81[Abstract/Free Full Text]
  10. Peter K, Schwarz M, Ylanne J. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa inhibitors. Blood. 1998;92:3240–3249[Abstract/Free Full Text]
  11. Honda S, Tomiyama Y, Aoki T. Association between ligand-induced conformational changes of integrin IIbbeta3 and IIbbeta3 mediated intracellular Ca2+ signaling. Blood. 1998;92:3675–3683[Abstract/Free Full Text]
  12. Cox D, Smith R, Quinn M. Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes. J Am Coll Cardiol. 2000;36:1514–1519[Abstract/Free Full Text]
  13. Stephens G, O'Luanaigh N, Reilly D. A sequence within the cytoplasmic tail of GPIIb independently activates platelet aggregation and thromboxane synthesis. J Biol Chem. 1998;273:20317–20322[Abstract/Free Full Text]
  14. Holmes MB, Sobel BE, Cannon CP, Schneider DJ. Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy. Orbofibanin Patients with Unstable coronary Syndromes. Thrombolysis In Myocardial Infarction. Am J Cardiol. 2000;85:491–493[CrossRef][ISI][Medline]
  15. Adderley SR, Fitzgerald DJ. Glycoprotein IIb/IIIa antagonists induce apoptosis in rat cardiomyocytes by capsase C activation. J Biol Chem. 2000;275:5760–5766[Abstract/Free Full Text]
  16. Akkerhuis KM, Neuhaus K-L, Wilcox RG. Safety and preliminary efficacy of one month's glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation: a phase II study. Eur Heart J. 2000;21:2042–2055[Abstract/Free Full Text]
  17. Muller TH, Weisenberger H, Brickl R, Narjes H, Himmelsbach F, Krause J. Profound and sustained inhibition of platelet aggregation by fradafiban, a non-peptide platelet glycoprotein IIb/IIIa antagonist and its orally active prodrug, lefradafiban, in men. Circulation. 1997;96:1130–1138[Abstract/Free Full Text]
  18. Byrne A, Moran N, Maher M, Walsh N, Crean P, Fitzgerald DJ. Continued Thromboxane A2formation despite administration of a platelet glycoprotein IIb/IIIa antagonist in patients undergoing coronary angioplasty. Arteriosc Thromb Vasc Biol. 1997;17:3224–3229[Abstract/Free Full Text]
  19. Antman EM, Tanasijevic MJ, Thompson B. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342–1349[Abstract/Free Full Text]
  20. Hamm CW, Heeschen C, Goldmann BU. Benefit of abciximab in patients with Refractory unstable angina in relation to serum troponin T levels: c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) study investigators. N Engl J Med. 1999;340:1623–1629[Abstract/Free Full Text]
  21. Heeschen C, Hamm CW, Goldmann B, Deu A, Langenbrink L, White HD. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to the therapeutic efficiency of tirofiban. PRISM study investigators. Platelet Receptor Inhibition in Ischaemic Syndrome Management. Lancet. 1999;354:1757–1762[CrossRef][ISI][Medline]
  22. Quinn M, Deering A, Stewart M, Cox D, Foley B, Fitzgerald DJ. Quantifying GPIIb/IIIa receptor binding using 2 monoclonal antibodies: discriminating abciximab and small molecular weight antagonists. Circulation. 1999;99:2231–2238[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
J. E. Freedman
Molecular Regulation of Platelet-Dependent Thrombosis
Circulation, October 25, 2005; 112(17): 2725 - 2734.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Curtin, R.
Right arrow Articles by Fitzgerald, D.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curtin, R.
Right arrow Articles by Fitzgerald, D.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?